DPIIT recognised startup Government of India
Startup India
Vitabolik Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.95 Lakh
▼ 64% YoY
Net loss · FY 2025
₹17.39 Lakh
Net margin -43.5%
EBITDA · FY 2025
-₹12.82 Lakh
EBITDA margin -32.1%
Authorised capital
₹4.25 Cr
Registered with MCA
Paid-up capital
₹4.17 Cr
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
47
Provident fund records
Directors on board
3
As per MCA filings
About Vitabolik Pharmaceuticals Private Limited
Data last updated:
Vitabolik Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33309MH2017PTC295602. Its GSTIN is 19AAFCV9486K1ZC (West Bengal).
The company has an authorised share capital of ₹4.25 Cr and a paid-up capital of ₹4.17 Cr. It is led by directors including Subhasis Dasgupta and Suman Dey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/205 2nd Floor Damji Shamji Corporate Square Off Ghatkopar Andhri Link Road, Mumbai, Maharashtra, India – 400075.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.95 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹17.39 Lakh (net margin -43.5%) and EBITDA of -₹12.82 Lakh (EBITDA margin -32.1%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 25% over five years.
The company has about 47 employees on its provident fund (EPFO) records.
The company has 4 deals on record (4 rights issues); the latest was in August 2021.
Vitabolik Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0039172). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vitabolikpharma.com.
Company details
CIN U33309MH2017PTC295602
Registration Number 295602
Incorporation Date 31 May 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0039172
Recognitions & Rankings of Vitabolik Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0039172
Contact details
Vitabolik Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is vitabolikpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB/205 2nd Floor Damji Shamji Corporate Square Off Ghatkopar Andhri Link Road, Mumbai, Maharashtra, India – 400075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vitabolik Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Vitabolik Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vitabolik Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vitabolik Pharmaceuticals Private Limited, buy the company report.
Financials of Vitabolik Pharmaceuticals Private Limited
FY 2025 filings availableVitabolik Pharmaceuticals Private Limited reported revenue of ₹39.95 Lakh (down 64% YoY) for FY 2025.
Revenue · FY 2025
₹39.95 Lakh ▼ 64%
Net loss · FY 2025
₹17.39 Lakh margin -43.5%
EBITDA · FY 2025
-₹12.82 Lakh margin -32.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 64%
3 years · compounded
▼ 36%
5 years · compounded
▼ 25%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 59%
5 years · compounded
▲ 47%
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 64% fall in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹17.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.1% | ||||
| Net Profit Margin | -43.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vitabolik Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vitabolik Pharmaceuticals Private Limited
Vitabolik Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhasis Dasgupta Also directs: Kalyan Stores (Dhatrigram) Pvt Ltd, Ma Sarada Cold Storage Pvt Ltd, Agrani Ice and Cold Storage Pvt Ltd and 3 more | Director | 31 May 2017 | 9 Years 4 Months | Current |
| Suman Dey Also directs: Hubspot Services LLP | Director | 31 May 2017 | 9 Years 4 Months | Current |
| Susil Kumar Misra Also directs: Ghanashyam Misra & Sons Pvt Ltd, Amalgam Steel Private Limited, GM Bidyut Limited. and 5 more | Director | 30 Sep 2019 | 7 Years 0 Months | Current |
Auditor
Vitabolik Pharmaceuticals Private Limited is audited by RAJESH R L AGARWAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH R L AGARWAL & CO | FY 2023 | 327361E |
Shareholding
The shareholding of Vitabolik Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vitabolik Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Vitabolik Pharmaceuticals Private Limited has 4 deals on record (4 rights issues); the latest was in August 2021.
Total deals
4
Rights issues
4
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Rights issue | ₹1.98 Cr | Investors: Charnock Hospitals Private Limited |
| Nov 2019 | Rights issue | ₹5.48 Cr | Investors: Ghanashyam Misra & Sons Pvt Ltd , Charnock Hospitals Private Limited |
| May 2018 | Rights issue | ₹1.78 Cr | Investors: Susil Kumar Misra & Others Huf, S K Misra Realty Private Limited , 2 individuals |
| Aug 2017 | Rights issue | ₹1.72 Cr | Investors: Kalyan Stores (Dhatrigram) Pvt Ltd , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vitabolik Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitabolik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vitabolik Pharmaceuticals Private Limited has a workforce of 47 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
47
Active EPFO establishments
1
Employee growth
34.29%
GST
Vitabolik Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAFCV9486K1ZC | West Bengal | Active | 18 Aug 2017 |
To see the full GST registrations and return filing status of Vitabolik Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vitabolik Pharmaceuticals Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Hemal Shah ceased to be Director on 06 Jul 2023.
AGM
Vitabolik Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vitabolik Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Hemal Shah ceased to be Director.
Appointed
Susil Kumar Misra was appointed as Director.
Appointed
Hemal Shah was appointed as Director.
Appointed
Subhasis Dasgupta was appointed as Director.
Appointed
Suman Dey was appointed as Director.
Incorporation
31 May 2017
Vitabolik Pharmaceuticals Private Limited was registered on 31 May 2017 with Roc Mumbai I & aged 9 years 4 months as per MCA records.
Frequently asked questions
Vitabolik Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2017 (9+ years old) and is registered under CIN U33309MH2017PTC295602.
Vitabolik Pharmaceuticals has 3 current directors:
- Subhasis Dasgupta - Director
- Suman Dey - Director
- Susil Kumar Misra - Director
The latest financial statements of Vitabolik Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Vitabolik Pharmaceuticals is 19AAFCV9486K1ZC, registered in West Bengal.
The CIN (Corporate Identification Number) of Vitabolik Pharmaceuticals is U33309MH2017PTC295602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitabolik Pharmaceuticals was incorporated on 31 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Vitabolik Pharmaceuticals has 4 deals on record (4 rights issues); the latest was in August 2021.
Hemal Shah ceased to be Director on 06 Jul 2023. Susil Kumar Misra was appointed as Director on 30 Sep 2019. Hemal Shah was appointed as Director on 31 May 2017. Vitabolik Pharmaceuticals has 5 board changes on record in total.
Yes, Vitabolik Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Vitabolik Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0039172).